Abstract:Purpose: Traumatic spinal cord injury (TSCI) induces a powerful inflammatory response that can significantly exacerbate the extent and severity of neural damage (termed as "secondary injury"). Thus, the suppression of inflammation is crucial for reducing neurological dysfunction following TSCI. However, the conventional anti-inflammatory drugs show limited efficacy because of poor penetration and release kinetics at the injury site. This study describes the design, synthesis, release kinetics, biosafety, and preclinical efficacy of mino-cycline (MC)-loaded poly(alpha-lipoic acid)-methylprednisolone (P alpha LA-MP) prodrug nanopartides (NPs) for the combined anti-inflammatory treatment of TSCI. Methods: NPs were produced by conjugating MP to P alpha LA and then loading MC. The NP structure was confirmed through H-1 nuclear magnetic resonance (H-1 NMR), Fourier transform infrared spectroscopy, ultraviolet-visible absorption spectroscopy, gel permeation chromatography, dynamic light scattering, and transmission electron microscopy. Drug-loading content and efficacy were measured using high-performance liquid chromatography (HPLC) or H-1 NMR and release kinetics through HPLC. Biosafety was examined using the MTT assay, cell penetration efficiency using confocal microscopy, and flow cytometry using Cyanine5 (Cy5)-labeled MC-P alpha LA-MP NPs, effects on injury-induced pro-inflammatory cytokine release using enzyme-linked immunosorbent assays and immunofluorescence, and treatment efficacy by measuring motor recovery in a rat model of TSCI. Results: The MC-P alpha LA-MP NPs exhibited high biocompatibility and released 81% MC and 54% MP within 24 h under TSCI-like conditions, effectively reducing 40% of pro-inflammatory cytokine release both in cultures and injured rat spinal cord tissues. Systemic injection increased the Basso, Beattie, Bresnahan score of TSCI rats from 2.33 +/- 0.52 to 8.83 +/- 1.83 in 8 weeks, providing effective neuroprotection and enhanced exercise recovery in the TSCI rats. Conclusion: The MC-P alpha LA-MP NPs can mitigate secondary inflammation and preserve motor function following experimental TSCI, which suggests their potential for clinical application.

Preparation of a minocycline polymer micelle thermosensitive gel and its application in spinal cord injury

An Injectable Recombinant Human Milk Fat Globule Epidermal Growth Factor 8 Loaded Copolymer System for Spinal Cord Injury Reduces Inflammation Through NF-B and Neuronal Cell Death

Mechanics-Electro-Adaptive Multifunctional Bioactive Nanocomposites Hydrogel for Inducing Spinal Cord Regeneration

Combinational Protective Therapy for Spinal Cord Injury Medicated by Sialic Acid-Driven and Polyethylene Glycol Based Micelles.

Bisphosphonate-Based Hydrogel with Ph-Responsive Minocycline Release Inhibits Microglia/Macrophages of M1 Polarization for Spinal Cord Injury Therapy

Novel multi-drug delivery hydrogel using scar-homing liposomes improves spinal cord injury repair.

A novel hydrogel-based combination therapy for effective neuroregeneration after spinal cord injury

Scar Tissue-Targeting Polymer Micelle for Spinal Cord Injury Treatment

Minocycline-Loaded Poly(-Lipoic Acid)-Methylprednisolone Prodrug Nanoparticles for the Combined Anti-Inflammatory Treatment of Spinal Cord Injury

Preparation of Drug Sustained-Release Scaffold with De-Epithelized Human Amniotic Epithelial Cells and Thiolated Chitosan Nanocarriers and Its Repair Effect on Spinal Cord Injury

Correction to “Polysialic-Acid-based Micelles Promote Neural Regeneration in Spinal Cord Injury Therapy”

Minocycline-Loaded Poly(α-Lipoic Acid)–Methylprednisolone Prodrug Nanoparticles for the Combined Anti-Inflammatory Treatment of Spinal Cord Injury

Biomimetic nanoplatform with anti-inflammation and neuroprotective effects for repairing spinal cord injury in mice

Zeolitic imidazole framework-8 loaded gelatin methacryloyl microneedles: A transdural and controlled-release drug delivery system attenuates neuroinflammation after spinal cord injury

Injectable, Adhesive, Self-Healing and Conductive Hydrogels Based on MXene Nanosheets for Spinal Cord Injury Repair

Local Administration of Methylated Prednisolone Comprising Solid Lipid Nanoparticles Improves Post Traumatic Spinal Cord Injury

Injectable Hydrogel Microspheres Encapsulating Extracellular Vesicles Derived from Melatonin-Stimulated NSCs Promote Neurogenesis and Alleviate Inflammation in Spinal Cord Injury

Effectiveness of Insolubilized Poly(vinyl alcohol)-Based Electrospun Fiber-Loaded Methylprednisolone by Enzyme-Catalyzed Cross-Linking in a Rat Spinal Cord Injury Model

Novel optimized drug delivery systems for enhancing spinal cord injury repair in rats

Neuroprotective Effects of Microglial Membrane‐Derived Biomimetic Particles for Spinal Cord Injury

Zonisamide-loaded Triblock Copolymer Nanomicelles As a Novel Drug Delivery System for the Treatment of Acute Spinal Cord Injury.